These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19447208)

  • 101. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Advances in novel drug delivery strategies for breast cancer therapy.
    Dhankhar R; Vyas SP; Jain AK; Arora S; Rath G; Goyal AK
    Artif Cells Blood Substit Immobil Biotechnol; 2010 Oct; 38(5):230-49. PubMed ID: 20677900
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern.
    Akhter S; Ahmad Z; Singh A; Ahmad I; Rahman M; Anwar M; Jain GK; Ahmad FJ; Khar RK
    Curr Pharm Des; 2011; 17(18):1834-50. PubMed ID: 21568874
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
    Ding H; Zhang J; Zhang F; Xu Y; Liang W; Yu Y
    Drug Deliv; 2022 Dec; 29(1):3218-3232. PubMed ID: 36259505
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Nanosponge Approach -A Plethora of Opportunities as a Promising Nanocarrier for Novel Drug Delivery.
    Bhavin SE; Anuradha G
    Recent Pat Nanotechnol; 2022; 16(4):271-282. PubMed ID: 34303335
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Self-assembling nanocarriers from engineered proteins: Design, functionalization, and application for drug delivery.
    Li Y; Champion JA
    Adv Drug Deliv Rev; 2022 Oct; 189():114462. PubMed ID: 35934126
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Insights into nucleic acid-based self-assembling nanocarriers for targeted drug delivery and controlled drug release.
    Chen K; Zhang Y; Zhu L; Chu H; Shao X; Asakiya C; Huang K; Xu W
    J Control Release; 2022 Jan; 341():869-891. PubMed ID: 34952045
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Implications of biomimetic nanocarriers in targeted drug delivery.
    Al-Hetty HRAK; Kadhim MS; Al-Tamimi JHZ; Ahmed NM; Jalil AT; Saleh MM; Kandeel M; Abbas RH
    Emergent Mater; 2023; 6(1):1-13. PubMed ID: 36686331
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Advances in Polymeric Colloids for Cancer Treatment.
    Ali I; Althakfi SH; Suhail M; Locatelli M; Hsieh MF; Alsehli M; Hameed AM
    Polymers (Basel); 2022 Dec; 14(24):. PubMed ID: 36559812
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Hybrid Nanocarriers for Neurological Disorders: Diagnostic & Therapeutic Approach.
    Mishra A; Ahsan R; Islam A; Tiwari RK; Dash PP
    Recent Pat Nanotechnol; 2024; 18(2):164-178. PubMed ID: 36028962
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Editorial: Protein-based nanocarriers for delivery of nutraceutical, diagnostic and therapeutic agents.
    Zhong J; Qiao R; Yuan WE
    Front Pharmacol; 2022; 13():991474. PubMed ID: 36003499
    [No Abstract]   [Full Text] [Related]  

  • 112. Polymers as Efficient Non-Viral Gene Delivery Vectors: The Role of the Chemical and Physical Architecture of Macromolecules.
    Khan M
    Polymers (Basel); 2024 Sep; 16(18):. PubMed ID: 39339093
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Targeted Nano-Based Systems for the Anti-Obesity Agent's Delivery.
    Engin AB; Engin ED; Engin A
    Adv Exp Med Biol; 2024; 1460():657-676. PubMed ID: 39287868
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Porous Silica Nanomaterials as Carriers of Biologically Active Natural Polyphenols: Effect of Structure and Surface Modification.
    Trendafilova I; Popova M
    Pharmaceutics; 2024 Jul; 16(8):. PubMed ID: 39204349
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Biopolymeric nanocarriers in cancer therapy: unleashing the potency of bioactive anticancer compounds for enhancing drug delivery.
    Hadkar VM; Mohanty C; Selvaraj CI
    RSC Adv; 2024 Aug; 14(35):25149-25173. PubMed ID: 39139249
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Recent advances in nanomaterial-based drug delivery systems for melanoma therapy.
    Parhi R; Kaishap PP; Jena GK
    ADMET DMPK; 2024; 12(1):107-150. PubMed ID: 38560710
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Stage-specific treatment of colorectal cancer: A microRNA-nanocomposite approach.
    Fadaka AO; Akinsoji T; Klein A; Madiehe AM; Meyer M; Keyster M; Sikhwivhilu LM; Sibuyi NRS
    J Pharm Anal; 2023 Nov; 13(11):1235-1251. PubMed ID: 38174117
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Microfluidic-Assisted Formulation of ε-Polycaprolactone Nanoparticles and Evaluation of Their Properties and In Vitro Cell Uptake.
    Rybak E; Kowalczyk P; Czarnocka-Śniadała S; Wojasiński M; Trzciński J; Ciach T
    Polymers (Basel); 2023 Nov; 15(22):. PubMed ID: 38006099
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Topical Formulations Based on Ursolic Acid-Loaded Nanoemulgel with Potential Application in
    Miastkowska M; Kulawik-Pióro A; Lasoń E; Śliwa K; Malinowska MA; Sikora E; Kantyka T; Bielecka E; Maksylewicz A; Klimaszewska E; Ogorzałek M; Tabaszewska M; Skoczylas Ł; Nowak K
    Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004538
    [No Abstract]   [Full Text] [Related]  

  • 120. Development of Ferroelectric P(VDF-TrFE) Microparticles for Ultrasound-Driven Cancer Cell Killing.
    Silva Pedraza Z; Wang Y; Carlos C; Tang Z; Li J; Cai W; Wang X
    ACS Appl Mater Interfaces; 2023 Nov; 15(47):54304-54311. PubMed ID: 37962532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.